126 related articles for article (PubMed ID: 11365530)
1. Giving improper dose of HIV drug is not proof of indifference.
AIDS Policy Law; 1998 Jun; 13(12):9. PubMed ID: 11365530
[TBL] [Abstract][Full Text] [Related]
2. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
3. U.S. Supreme Court rules ADA applies to correctional facilities.
AIDS Policy Law; 1998 Jun; 13(12):1, 8. PubMed ID: 11365515
[TBL] [Abstract][Full Text] [Related]
4. ACTG 320: last of the body count trials?
PI Perspect; 1997 Mar; (No 21):7. PubMed ID: 11364215
[TBL] [Abstract][Full Text] [Related]
5. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
6. Inmate has no constitutional right to a protease inhibitor, court says.
AIDS Policy Law; 1999 Feb; 14(3):1, 6. PubMed ID: 11366320
[TBL] [Abstract][Full Text] [Related]
7. 3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
Baker R
BETA; 1997 Mar; ():3-4. PubMed ID: 11364527
[TBL] [Abstract][Full Text] [Related]
8. Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine.
Cahn P; Vibhagool A; Schechter M; Soto-Ramirez L; Carosi G; Smaill F; Jordan JC; Pharo CE; Thomas NE; Steel HM
Curr Med Res Opin; 2004 Jul; 20(7):1115-23. PubMed ID: 15265256
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy danger.
Posit Aware; 1998; 9(5):18. PubMed ID: 11365886
[TBL] [Abstract][Full Text] [Related]
10. ACTG 343: (why) we can't relax our grip on viral suppression.
Maenza JR
Hopkins HIV Rep; 1998 May; 10(3):10. PubMed ID: 11365491
[TBL] [Abstract][Full Text] [Related]
11. Protease inhibitors: major study stopped when 3-drug arm proves superior.
AIDS Treat News; 1997 Mar; (No 266):7-8. PubMed ID: 11364247
[TBL] [Abstract][Full Text] [Related]
12. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
[TBL] [Abstract][Full Text] [Related]
13. [A two-year follow-up of zidovudine plus lamivudine combined with indinavir in antivival naive HIV-infected patients].
Aizawa S; Sakai-Hachiya A; Ida S; Tachikawa N; Kikuchi Y; Aoki M; Yasuoka A; Oka S
Kansenshogaku Zasshi; 2000 Feb; 74(2):128-33. PubMed ID: 10741003
[TBL] [Abstract][Full Text] [Related]
14. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
[No Abstract] [Full Text] [Related]
15. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
[TBL] [Abstract][Full Text] [Related]
16. Inmate can't demand new cell because he fears cellmate has HIV.
AIDS Policy Law; 1995 Feb; 10(2):11. PubMed ID: 11362219
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
[TBL] [Abstract][Full Text] [Related]
18. Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient.
Tachikawa N; Yasuoka A; Oka S
Jpn J Infect Dis; 1999 Dec; 52(6):245-6. PubMed ID: 10738363
[No Abstract] [Full Text] [Related]
19. Zidovudine + lamivudine: new preparation. Fewer tablets required.
Prescrire Int; 1999 Apr; 8(40):39-40. PubMed ID: 10848057
[TBL] [Abstract][Full Text] [Related]
20. [HIV-therapy: as early and as intensive as possible].
Dtsch Med Wochenschr; 1997 Oct; 122(41):A27. PubMed ID: 9378051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
